0001493152-23-006675.txt : 20230303 0001493152-23-006675.hdr.sgml : 20230303 20230303161026 ACCESSION NUMBER: 0001493152-23-006675 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230303 FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CASAMENTO CHARLES J CENTRAL INDEX KEY: 0001117167 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38738 FILM NUMBER: 23704006 MAIL ADDRESS: STREET 1: 99 BELBROOK WAY CITY: ATHERTON STATE: CA ZIP: 94027 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eton Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001710340 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 371858472 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21925 W. FIELD PARKWAY STREET 2: SUITE 235 CITY: DEER PARK STATE: IL ZIP: 60010-7278 BUSINESS PHONE: (847) 787-7361 MAIL ADDRESS: STREET 1: 21925 W. FIELD PARKWAY STREET 2: SUITE 235 CITY: DEER PARK STATE: IL ZIP: 60010-7278 4 1 ownership.xml X0306 4 2023-03-03 0 0001710340 Eton Pharmaceuticals, Inc. ETON 0001117167 CASAMENTO CHARLES J 21925 W FIELD PKWY, SUITE 235 DEER PARK IL 60010-7278 1 0 0 0 Stock Option (Right to buy) 3.47 2023-03-03 4 A 0 25000 0.00 A 2033-02-19 Common stock 25000 134555 D Option was approved by the Compensation Committee of the Board of Directors as of February 20, 2023 and approved by the full Board of Directors on March 3, 2023. The shares subject to the option shall vest on a quarterly basis over 12 months form the date of grant until fully vested and exercisable on February 20, 2024. The reporting person has authorized and designated the named person to file this Form 4 on the reporting person's behalf for indefinite duration. /s/ James R Gruber 2023-03-03